Market Research Report
Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030
|Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030|
Published: February 28, 2022
Content info: 26 Pages
Delivery time: 1-2 business days
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004). In general, the prevalence of AD is increasing worldwide, with high prevalence in Western and developed nations compared with other parts of the world. However, recent trends demonstrate a gradual rise in prevalence in developing countries and plateauing prevalence in developed countries (Asher et al., 2006). Although AD is not life-threatening, it has a huge impact on the patient's quality of life and causes a significant economic burden (Carroll et al., 2005).
GlobalData epidemiologists utilized nationally representative and country-specific peer-reviewed journal articles to arrive at a meaningful, in-depth analysis and forecast for the 12-month diagnosed prevalent cases of AD. For the 7MM, diagnosed prevalent cases of AD were segmented by age, sex, and severity.
GlobalData epidemiologists forecast that the 12-month diagnosed prevalent cases of AD in the 7MM will grow by an annual growth rate (AGR) of 0.03% over the next 10 years, from 42,138,193 cases in 2020 to 42,245,459 cases in 2030. Trends in the 7MM and specific markets can be attributed in part to changes in the underlying population structure. As atopic dermatitis is most frequently diagnosed in children and adolescents, the condition inflicts considerable psychosocial and economic burden on the families of the affected. More research is needed to understand the etiological factors associated with AD to take preventive measures and reduce these burdens.
The AD Epidemiology series will allow you to -